Cargando…

Correlation of clinical and molecular features in spinal bulbar muscular atrophy

OBJECTIVES: To characterize the clinical and genetic features of spinal bulbar muscular atrophy (SBMA), a rare neurodegenerative disorder caused by the expansion of a CAG repeat in the first exon of the androgen receptor gene, in the United Kingdom. METHODS: We created a national register for SBMA i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fratta, Pietro, Nirmalananthan, Niranjanan, Masset, Luc, Skorupinska, Iwona, Collins, Toby, Cortese, Andrea, Pemble, Sally, Malaspina, Andrea, Fisher, Elizabeth M.C., Greensmith, Linda, Hanna, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075620/
https://www.ncbi.nlm.nih.gov/pubmed/24814851
http://dx.doi.org/10.1212/WNL.0000000000000507
_version_ 1782323365206294528
author Fratta, Pietro
Nirmalananthan, Niranjanan
Masset, Luc
Skorupinska, Iwona
Collins, Toby
Cortese, Andrea
Pemble, Sally
Malaspina, Andrea
Fisher, Elizabeth M.C.
Greensmith, Linda
Hanna, Michael G.
author_facet Fratta, Pietro
Nirmalananthan, Niranjanan
Masset, Luc
Skorupinska, Iwona
Collins, Toby
Cortese, Andrea
Pemble, Sally
Malaspina, Andrea
Fisher, Elizabeth M.C.
Greensmith, Linda
Hanna, Michael G.
author_sort Fratta, Pietro
collection PubMed
description OBJECTIVES: To characterize the clinical and genetic features of spinal bulbar muscular atrophy (SBMA), a rare neurodegenerative disorder caused by the expansion of a CAG repeat in the first exon of the androgen receptor gene, in the United Kingdom. METHODS: We created a national register for SBMA in the United Kingdom and recruited 61 patients between 2005 and 2013. In our cross-sectional study, we assessed, by direct questioning, impairment of activities of daily living (ADL) milestones, functional rating, and subjective disease impact, and performed correlations with both CAG repeat size and degree of somatic mosaicism. Ten patients were deceased, 46 patients participated in the study, and 5 declined. RESULTS: Subjects had an average age at onset of 43.4 years, and weakness onset most frequently occurred in the lower limbs (87%). Impaired mobility was the most frequently reported problem by patients, followed by bulbar dysfunction. Age distribution of the impairment of ADL milestones showed remarkable overlap with a Japanese study. We have identified a significant correlation between the number of CAG repeats and both age at onset and ADL milestones. Somatic mosaicism also showed a correlation with CAG expansion size and age at onset. CONCLUSIONS: Clinical features in SBMA show a substantial overlap when comparing populations with different genetic backgrounds. This finding has major implications, because multicenter trials will be necessary to obtain sufficient power in future clinical trials. Clinical-genetic correlations are strong in SBMA and should inform any clinical research strategy in this condition.
format Online
Article
Text
id pubmed-4075620
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-40756202014-07-10 Correlation of clinical and molecular features in spinal bulbar muscular atrophy Fratta, Pietro Nirmalananthan, Niranjanan Masset, Luc Skorupinska, Iwona Collins, Toby Cortese, Andrea Pemble, Sally Malaspina, Andrea Fisher, Elizabeth M.C. Greensmith, Linda Hanna, Michael G. Neurology Article OBJECTIVES: To characterize the clinical and genetic features of spinal bulbar muscular atrophy (SBMA), a rare neurodegenerative disorder caused by the expansion of a CAG repeat in the first exon of the androgen receptor gene, in the United Kingdom. METHODS: We created a national register for SBMA in the United Kingdom and recruited 61 patients between 2005 and 2013. In our cross-sectional study, we assessed, by direct questioning, impairment of activities of daily living (ADL) milestones, functional rating, and subjective disease impact, and performed correlations with both CAG repeat size and degree of somatic mosaicism. Ten patients were deceased, 46 patients participated in the study, and 5 declined. RESULTS: Subjects had an average age at onset of 43.4 years, and weakness onset most frequently occurred in the lower limbs (87%). Impaired mobility was the most frequently reported problem by patients, followed by bulbar dysfunction. Age distribution of the impairment of ADL milestones showed remarkable overlap with a Japanese study. We have identified a significant correlation between the number of CAG repeats and both age at onset and ADL milestones. Somatic mosaicism also showed a correlation with CAG expansion size and age at onset. CONCLUSIONS: Clinical features in SBMA show a substantial overlap when comparing populations with different genetic backgrounds. This finding has major implications, because multicenter trials will be necessary to obtain sufficient power in future clinical trials. Clinical-genetic correlations are strong in SBMA and should inform any clinical research strategy in this condition. Lippincott Williams & Wilkins 2014-06-10 /pmc/articles/PMC4075620/ /pubmed/24814851 http://dx.doi.org/10.1212/WNL.0000000000000507 Text en © 2014 American Academy of Neurology This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Fratta, Pietro
Nirmalananthan, Niranjanan
Masset, Luc
Skorupinska, Iwona
Collins, Toby
Cortese, Andrea
Pemble, Sally
Malaspina, Andrea
Fisher, Elizabeth M.C.
Greensmith, Linda
Hanna, Michael G.
Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title_full Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title_fullStr Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title_full_unstemmed Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title_short Correlation of clinical and molecular features in spinal bulbar muscular atrophy
title_sort correlation of clinical and molecular features in spinal bulbar muscular atrophy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075620/
https://www.ncbi.nlm.nih.gov/pubmed/24814851
http://dx.doi.org/10.1212/WNL.0000000000000507
work_keys_str_mv AT frattapietro correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT nirmalananthanniranjanan correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT massetluc correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT skorupinskaiwona correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT collinstoby correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT corteseandrea correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT pemblesally correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT malaspinaandrea correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT fisherelizabethmc correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT greensmithlinda correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy
AT hannamichaelg correlationofclinicalandmolecularfeaturesinspinalbulbarmuscularatrophy